Search Results - "A. Di Biagio"

Bloodstream infections in patients living with HIV in the modern cART era by Taramasso, L., Liggieri, F., Cenderello, G., Bovis, F., Giannini, B., Mesini, A., Giacomini, M., Cassola, G., Viscoli, C., Di Biagio, A.

“…Retrospective multicentre study aiming at analysing the etiology, characteristics and outcome of bloodstream infections (BSI) in people living with HIV…”
Get full text

Prevalence and determinants of resistance mutations in HIV‐1‐infected patients exposed to integrase inhibitors in a large Italian cohort by Modica, S, Rossetti, B, Lombardi, F, Lagi, F, Maffeo, M, D'Autilia, R, Pecorari, M, Vicenti, I, Bruzzone, B, Magnani, G, Paolucci, S, Francisci, D, Penco, G, Sacchini, D, Zazzi, M, De Luca, A, Di Biagio, A

“…Objectives The aim of the study was to analyse the prevalence of integrase resistance mutations in integrase strand transfer inhibitor (INSTI)‐experienced…”
Get full text

Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use by Maggi, P, De Socio, G V, Cicalini, S, D'Abbraccio, M, Dettorre, G, Di Biagio, A, Martinelli, C, Nunnari, G, Rusconi, S, Sighinolfi, L, Spagnuolo, V, Squillace, N

“…As in non-infected subjects, statins and aspirin have a pivotal preventive role in reducing the cardiovascular related morbidity and mortality in HIV infected…”
Get full text

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort by Taramasso, L, Fabbiani, M, Nozza, S, De Benedetto, I, Bruzzesi, E, Mastrangelo, A, Pinnetti, C, Calcagno, A, Ferrara, M, Bozzi, G, Focà, E, Quiros‐Roldan, E, Ripamonti, D, Campus, M, Celesia, BM, Torti, C, Cosco, L, Di Biagio, A, Rusconi, S, Marchetti, G, Mussini, C, Gulminetti, R, Cingolani, A, d’Ettorre, G, Madeddu, G, Franco, A, Orofino, G, Squillace, N, Muscatello, A, Gori, A, Antinori, A, Tambussi, G, Bandera, A

“…Objectives The aim of this study was to evaluate the factors that can influence an incomplete viral response (IVR) after acute and early HIV infection (AEHI)…”
Get full text

The role of hepatitis B vaccine challenge dose in patients with underlying health conditions by Sticchi, L., Iavarone, I. G., Durando, P., Di Biagio, A., Schiavetti, I., Murgia, F., Icardi, G.

“…We have evaluated the immunological response to Hepatitis B virus (HBV) booster vaccine dose in 129 adults with underlying diseases in comparison with 694…”
Get full text

Missed opportunities to prevent mother‐to‐child transmission of HIV in Italy by Di Biagio, A, Taramasso, L, Gustinetti, G, Burastero, G, Giacomet, V, La Rovere, D, Genovese, O, Giaquinto, C, Rampon, O, Carloni, I, Hyppolite, TK, Palandri, L, Bernardi, S, Bruzzese, E, Badolato, R, Gabiano, C, Chiappini, E, De Martino, M, Galli, L, Osimani, Patrizia, Larovere, Domenico, Ruggeri, Maurizio, Pession, Andrea, Faldella, Giacomo, Capra, Francesca, Pulcini, Sara, Zattoni, Valentina, Dotta, Laura, Aliffi, Antonia, Anastasio, Elisa, Fiumana, Elisa, Gervaso, Paola, Montagnani, Carlotta, Viscoli, Claudio, Erba, Paola, Zuccotti, GianVincenzo, Benincaso, Annarita, Salvini, Filippo, Lipreri, Rita, Esposito, Susanna, Plebani, Anna, Tagliabue, Claudia, Giubbarelli, Francesca, Nicastro, Emanuele, Lo Vecchio, Andrea, Buffolano, Wilma, Agnese, Maura, Romano, Amelia, Marcello, Saitta, Giaquinto, Carlo, Pennazzato, Martina, Consolini, Rita, Dodi, Icilio, Zanaboni, Domenico, Palma, Paolo, Pontrelli, Giuseppe, Tchidjou, Hyppolite, Mazza, Antonio, Tovo, Pier Angelo, Silvestro, Erika, Virano, Silvia, Portelli, Vincenzo, Pellegatta, Antonio

“…Objectives Vertical transmission of HIV can be effectively controlled through antenatal screening, antiretroviral treatment and the services provided during…”
Get full text

Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study by Di Biagio, A, Rosso, R, Vitale, F, Cardinale, F, Sormani, M P, Secondo, G, Di Stefano, L, Viscoli, C

“…Renal dysfunction is a common complication in human immunodeficiency virus (HIV)-infected patients and can be attributed to direct viral damage, comorbidities…”
Get more information

Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine by Calcagno, A., Coppola, N., Sarmati, L., Tadolini, M., Parrella, R., Matteelli, A., Riccardi, N., Trezzi, M., Di Biagio, A., Pirriatore, V., Russo, A., Gualano, G., Pontali, E., Surace, L., Falbo, E., Mencarini, J., Palmieri, F., Gori, A., Schiuma, M., Lapadula, G., Goletti, D.

“…Background Non-tuberculous mycobacteria (NTM) are generally free-living organism, widely distributed in the environment, with sporadic potential to infect. In…”
Get full text

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? by Vergori, A., Gagliardini, R., Gianotti, N., Gori, A., Lichtner, M., Saracino, A., De Vito, A., Cascio, A., Di Biagio, A., Monforte, A. d'Arminio, Antinori, A., Cozzi-Lepri, A.

“…•Switching from tenofovir disoproxil fumarate (TDF)-containing regimens has increased considerably in recent years.•A high proportion of people with a…”
Get full text

Penetration of didanosine in semen of HIV-1-infected men by Cruciani, M., Liuzzi, G., Chirianni, A., Audagnotto, S., Bonora, S., Di Biagio, A., Sinicco, A., Bassetti, M., Gatti, G.

“…Objectives: The disposition of antiretroviral agents into genital tissue and fluids is one of the factors implicated in the control of viral replication within…”
Get full text

Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA) by Rusconi, S., Adorni, F., Tau, P., Borghi, V., Pecorari, M., Maserati, R., Francisci, D., Monno, L., Punzi, G., Meraviglia, P., Paolucci, S., Di Biagio, A., Bruzzone, B., Mancon, A., Micheli, V., Zazzi, M.

“…•We analyzed durability and virological response to DTG-containing regimens.•After exposure to first-generation INIs, treatment with DTG showed long…”
Get full text

Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy) by Venturini, A., Cenderello, G., Di Biagio, A., Giannini, B., Ameri, M., Giacomini, M., Montefiori, M., Setti, M., Mazzarello, G., Merlano, C., Orcamo, P., Viscoli, C., Cassola, G.

“…The aims of this study were to assess the Health Related Quality of Life (HRQoL) of People Living with HIV/AIDS (PLWHA) who attend outpatient services in…”
Get full text

Rs12979860 and rs8099917 single nucleotide polymorphisms of interleukin-28B gene: simultaneous genotyping in caucasian patients infected with hepatitis C virus by Sticchi, L, Di Biagio, A, Rappazzo, E, Setti, M, De Rosa, G, De Hoffer, L, Nicolini, L, Prinapori, R, Bruzzone, B

“…Recent studies have demonstrated the role of the interleukin 28B (IL28B) polymorphisms in predicting treatment induced and spontaneous clearance from Hepatitis…”
Get full text

Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection by Rosso, Raffaella, Bernardini, C, Bruzzone, B, Secondo, G, Icardi, G, Viscoli, C, Di Biagio, A

“…Multiclass-drug resistance, often caused by poor treatment compliance, is a challenging problem in all categories of HIV-infected patients. Selective pressure…”
Get full text

Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data by Marcellusi, Andrea, Viti, Raffaella, Kondili, Loreta A., Rosato, Stefano, Vella, Stefano, Mennini, Francesco Saverio

“…Objective We estimated the cost consequence of Italian National Health System (NHS) investment in direct-acting antiviral (DAA) therapy according to hepatitis…”
Get full text

Influence of HIV-1 Co-Receptor Tropism on Liver Fibrosis in HIV-Infected Patients by Saracino, A, Cozzi-Lepri, A, Ceccherini Silberstein, F, Nozza, S, Di Biagio, A, Cassola, G, Bruno, G, Capobianchi, M, Monno, L, d’Arminio Monforte, A

Get full text

Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc by Dentone, C, Sterrantino, G, Signori, A, Cenderello, G, Guerra, M, De Leo, P, Bartolacci, V, Mantia, E, Orofino, G, Giacomini, M, Bruzzone, B, Francisci, D, Di Biagio, A

“…The aim of this retrospective, multicentre, observational study was to assess the durability, safety, immune recovery and effectiveness on viral suppression of…”
Get more information

Factors associated with virological success with raltegravir-containing regimens and prevalence of raltegravir-resistance-associated mutations at failure in the ARCA database by Rusconi, S., Vitiello, P., Adorni, F., Bruzzone, B., De Luca, A., Micheli, V., Meraviglia, P., Maserati, R., Di Pietro, M., Colao, G., Penco, G., Di Biagio, A., Punzi, G., Monno, L., Zazzi, M.

“…Raltegravir (RAL) is the only licensed human immunodeficiency virus (HIV) integrase inhibitor. The factors associated with the virological response to…”
Get full text

The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected Persons by Guaraldi, G, Marcotullio, S, Maserati, R, Gargiulo, M, Milic, J, Franconi, I, Chirianni, A, Andreoni, M, Galli, M, Lazzarin, A, D'Arminio Monforte, A, Di Perri, G, Perno, C-F, Puoti, M, Vella, S, Di Biagio, A, Maia, L, Mussi, C, Cesari, M, Antinori, A

“…This article deals with the attempt to join HIV and geriatric care management in the 2017 edition of the Italian guidelines for the use of antiretrovirals and…”
Get full text

Dasabuvir and Ombitasvir/Paritaprevir/Ritonavir with or without Ribavirin in Patients with HIV-HCV Coinfection: Real Life Interim Analysis of an Italian Multicentre Compassionate Use Program by Teti, E, Ricciardi, A, Antinori, A, Galli, M, Rizzardini, G, Di Biagio, A, Angarano, G, Bruno, R, Mussini, C, De Luca, A, Cattelan, A, Lazzarin, A, Taliani, G, D’Arminio Monforte, A, Mastroianni, C.M, Di Perri, G, Maggiolo, F, Puoti, M, Castelli, F, Gori, A, Boffa, N, Cacopardo, B, Giacometti, A, Parruti, G, Vullo, V, Chirianni, A, Pennica, A, Pasquazzi, C, Sighinolgi, L, Gentilotti, E, Sarmati, L, Andreoni, M

Get full text